|
Volumn 360, Issue 10, 2009, Pages
|
Rosuvastatin in patients with elevated C-reactive protein.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MARKER;
C REACTIVE PROTEIN;
FLUOROBENZENE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PYRIMIDINE DERIVATIVE;
ROSUVASTATIN;
SULFONAMIDE;
BLOOD;
CARDIOVASCULAR DISEASE;
HUMAN;
METABOLISM;
METHODOLOGY;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
RISK;
STATISTICAL ANALYSIS;
EPIDEMIOLOGY;
BIOLOGICAL MARKERS;
C-REACTIVE PROTEIN;
CARDIOVASCULAR DISEASES;
DATA INTERPRETATION, STATISTICAL;
FLUOROBENZENES;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
PYRIMIDINES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RESEARCH DESIGN;
RISK;
SULFONAMIDES;
BIAS (EPIDEMIOLOGY);
|
EID: 61849124241
PISSN: None
EISSN: 15334406
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (1)
|
References (0)
|